APR 07, 2020 7:37 AM PDT

Computers Predict Diabetes with 94.9 Percent Accuracy

WRITTEN BY: Tara Fernandez

"Currently we do not have sufficient methods for predicting which generally healthy individuals will develop diabetes," says Akihiro Nomura of Kanazawa University, author of a new study that used artificial intelligence (AI) as a clinical tool to predict diabetes.

Diabetes mellitus is a chronic condition that affects how the body metabolizes glucose. Patients with Type 1 and Type 2 diabetes have too much sugar in their blood, a condition that can result in serious health complications. A CDC report estimates that over 100 million Americans have either diabetes or prediabetes. However, the problem, as Nomura points out, is that healthcare providers do not have a good way of foreseeing who to focus clinical and lifestyle interventions on to prevent the future onset of diabetes — until now.

Machine learning is a type of AI in which computers can “learn”, without programming, to make connections out of large datasets. Making sense of massive amounts of data is often too complicated and overwhelming for the human brain to achieve. Additionally, machine learning systems get “smarter” as they are exposed to more data, creating an ever-evolving system that is better equipped at recognizing subtle patterns. In this study, the researchers fed the computer system over half a million health checkup records from over 139,000 participants over a decade. About half of these individuals did not have diabetes, while around 5,000 did go on to be diagnosed with the disease.

According to Nomura, "Using machine learning, it could be possible to precisely identify high-risk groups of future diabetes patients better than using existing risk scores." 

"In addition, the rate of visits to healthcare providers might be improved to prevent the future onset of diabetes." Impressively, the machine learning system predicted the future development of diabetes with an accuracy of 94.9 percent.

 

 

The researchers’ next steps involve clinical trials to assess the robustness of the system among larger cohorts and how pharmaceutical interventions such as statin treatment can change patient outcomes.

 


Sources: Medical XPress, Journal of the Endocrine Society.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAY 09, 2021
Genetics & Genomics
Another Neurodevelopmental Disorder is Discovered
MAY 09, 2021
Another Neurodevelopmental Disorder is Discovered
Researchers are identifying more rare disorders because of advances in genetic sequencing technologies, which have made ...
JUN 04, 2021
Cannabis Sciences
Neurotechnology and Saliva Tests Detect Psychoactive Effects of Cannabis
JUN 04, 2021
Neurotechnology and Saliva Tests Detect Psychoactive Effects of Cannabis
Researchers from contract research organization, KGK Science, working on behalf of neurotechnology firm Zentrela, have f ...
JUN 29, 2021
Immunology
Speed Up qPCR Sample Preparation for SARS-CoV-2 Detection
JUN 29, 2021
Speed Up qPCR Sample Preparation for SARS-CoV-2 Detection
Amid the widespread outbreak of the COVID-19 caused by SARS-CoV-2, the development of test methods that can efficiently ...
JUL 29, 2021
Clinical & Molecular DX
Sewage Sleuths: Tracking COVID Variants in Wastewater
JUL 29, 2021
Sewage Sleuths: Tracking COVID Variants in Wastewater
Since the dawn of the pandemic, one of the biggest challenges has been monitoring the crowned enemy as it spread through ...
AUG 05, 2021
Clinical & Molecular DX
Gene Markers in Mothers Point to the Risk of Preterm Birth
AUG 05, 2021
Gene Markers in Mothers Point to the Risk of Preterm Birth
Preterm births—when the baby is born fewer than 37 weeks gestational age—are very common. Experts estimate o ...
AUG 31, 2021
Clinical & Molecular DX
Five Questions to Help You Select the Best Cellular Stain
AUG 31, 2021
Five Questions to Help You Select the Best Cellular Stain
Cellular stains are organic fluorescent dyes or fluorescent conjugates designed to localize to a specific organelle or c ...
Loading Comments...